Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Source: SeekingAlpha
2026-05-12 23:54:49 ET
This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest 's 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 05/12/2026....
Read the full article on Seeking Alpha
For further details see:
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Intellia Therapeutics Inc.
NASDAQ: NTLA
NTLA Trading
16.52% G/L:
$14.92 Last:
5,880,089 Volume:
$13.20 Open:
NTLA Latest News
June 03, 2026 12:25:00 pm
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't
June 01, 2026 07:30:00 am
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
May 11, 2026 07:30:00 am
Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
April 29, 2026 07:00:00 am
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
NTLA Stock Data
$1,420,074,893
112,239,198
1.45%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
